Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Amyloidosis

P N Hawkins1

  • 1Immunological Medicine Unit, Royal Postgraduate Medical School, Hammersmith Hospital, London, UK.

Blood Reviews
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Amyloidosis involves amyloid deposition, a progressive and often fatal condition. Diagnosis requires tissue confirmation, but new imaging techniques and precursor-reducing therapies improve outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal Stenosis in Familial Transthyretin Amyloidosis.

Journal of neuromuscular diseases·2019
Same author

Extracardiac <sup>18</sup>F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds.

European journal of nuclear medicine and molecular imaging·2018
Same author

Measurement of liver and spleen interstitial volume in patients with systemic amyloid light-chain amyloidosis using equilibrium contrast CT.

Abdominal radiology (New York)·2017
Same author

Early-onset urticaria: a marker of cryopyrin-associated periodic syndrome.

Clinical and experimental dermatology·2017
Same author

Neurology of the cryopyrin-associated periodic fever syndrome.

European journal of neurology·2016
Same author

A study of the neuropathy associated with transthyretin amyloidosis (ATTR) in the UK.

Journal of neurology, neurosurgery, and psychiatry·2015
Same journal

Treating large B-cell lymphoma: Current strategies and unmet needs across community and academic settings.

Blood reviews·2026
Same journal

MRD in multiple myeloma: Moving from "minimal" to "measurable".

Blood reviews·2026
Same journal

PRISMA-based systematic review on iron stores in repeat blood donors.

Blood reviews·2026
Same journal

Artificial intelligence applications in thrombotic thrombocytopenic Purpura: A systematic review of diagnostic, risk stratification, and prognostic models.

Blood reviews·2026
Same journal

Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group.

Blood reviews·2026
Same journal

The Lebanese national patient blood management guidelines: A new page in the medical practice.

Blood reviews·2026
See all related articles

Area of Science:

  • Medicine
  • Pathology

Background:

  • Amyloidosis is a group of disorders characterized by amyloid deposition.
  • These conditions can be acquired or hereditary, classified by the specific amyloid fibril protein.
  • Systemic and some local forms are progressive and frequently fatal.

Purpose of the Study:

  • To provide an overview of amyloidosis, including its classification, diagnosis, and management.
  • To highlight the diagnostic challenges and advancements in detecting amyloid deposits.
  • To discuss therapeutic strategies aimed at reducing amyloid precursor proteins and improving patient outcomes.

Main Methods:

  • Classification based on amyloid fibril sub-unit protein identity.
  • Diagnostic confirmation through demonstration of tissue amyloid deposits.

Related Experiment Videos

  • Utilizing routine haematological and biochemical investigations to assess organ function and metabolic disturbance.
  • Employing labelled serum amyloid P component scintigraphy for whole-body amyloid deposit surveys.

    • Main Results:

    • Diagnosis is often suspected in the presence of associated disorders like chronic inflammatory disease or monoclonal gammopathy.
    • No single blood test is diagnostic; tissue confirmation is essential.
    • Serum amyloid P component scintigraphy offers a specific, quantitative, macroscopic whole-body survey.
    • Therapies reducing amyloid precursor protein supply can improve survival and organ function.
    • Major amyloid regression and clinical improvement suggest amyloid mobilization.

    Conclusions:

    • Amyloidosis diagnosis relies on identifying tissue amyloid deposits, with scintigraphy as a key advancement.
    • While no cure exists, reducing precursor protein supply is a viable therapeutic strategy.
    • Clinical improvement may indicate successful mobilization of amyloid deposits.